Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02795157n
Noun Named Entity
SYL
No term available
EN
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
Relations
Sources
IS A
EN
commercial enterprise
EN
public company
COUNTRY
ꠁꠎꠞꠣꠁꠟ
FOUNDED BY
EN
Joseph Chaaltiel
HEADQUARTERS LOCATION
Karmiel
INDUSTRY
EN
biotechnology
PRODUCT OR MATERIAL PRODUCED
EN
Taliglucerase alfa
STOCK EXCHANGE
American Stock Exchange
EN
Tel Aviv Stock Exchange

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License